Eneida R. Nemecek, M.D., M.S., M.B.A.

  • Professor of Medicine, School of Medicine
  • Professor of Pediatrics, School of Medicine
  • Medical Director for Clinical Research, OHSU Knight Cancer Institute, School of Medicine
  • Nancy Jaggar Blount Professor of Pediatric Oncology


Dr. Eneida Nemecek focuses her work on better understanding pediatric cancers and other diseases that can be treated with bone marrow transplantation.

She is medical director for clinical research within the OHSU Knight Cancer Institute. She works with other researchers at OHSU and around the world to better understand pediatric cancer and bone marrow transplants. She also collaborates with national and international groups working to better understand cancer and bone marrow transplants. Those groups include the Children's Oncology Group, the Pediatric Blood and Marrow Transplant Consortium, the Bone Marrow Transplant Clinical Trials Network and the Center for International Blood and Marrow Transplant Research.

Through these and other groups, bone marrow transplant patients at OHSU Doernbecher Children's Hospital have access to a variety of clinical trials testing pioneering treatments.

Education and training

    • B.S., 1992, University of Puerto Rico
    • M.D., 1996, University of Puerto Rico School of Medicine
    • M.S., 2004, University of Washington
    • M.B.A., 2013, Oregon Health & Science University
  • Residency

    • Pediatrics, Rainbow Babies and Children’s Hospital, Case Western Reserve University, 1999
  • Fellowship

    • Pediatric hematology/oncology, Fred Hutchinson Cancer Research Center, University of Washington, 2002
  • Certifications

    • National Board of Medical Examiners, 1997
    • American Board of Pediatric Subspecialties, Pediatrics (2000)
    • Pediatric Hematology/Oncology (2004)

Memberships and associations:

  • American Society of Pediatric Hematology/Oncology
  • American Society of Hematology
  • American Society of Transplantation & Cellular Therapy
  • International Society of Cell & Gene Therapy

Areas of interest

  • Graft vs. host disease
  • Diversity and Healthcare Disparities
  • Cellular therapies


Elsevier pure profile


  • {{ pub.journalAssociation.journal.name.text[0].value }}